Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Eur Rev Med Pharmacol Sci ; 27(3 Suppl): 1-10, 2023 04.
Article in English | MEDLINE | ID: mdl-37129330

ABSTRACT

OBJECTIVE: Treacher Collins syndrome (TCS) is a rare congenital disorder of craniofacial development. TCS occurs with an incidence of 1:50,000, and more than 60% of TCS cases have no previous family history and arise as the result of de novo mutations. The high rate of de novo mutations, together with the extreme variability in the degree to which individuals can be affected, makes the provision of genetic counseling extremely complicated. Consequently, every case of TCS is unique and needs to be assessed individually. Patients with TCS frequently undergo multiple reconstructive surgeries from birth through adulthood, which rarely are fully corrective in the long-term. The nascent field of regenerative medicine offers the promise to improve some of these treatments. In particular, structural fat grafting (SFG) seems to be a good strategy not only to restore the normal volume and contour of the face, but also to provide a source of adipose-derived stem cells (ADSCs) with a multilineage differentiation potential. In this work, we present genetical analyses of ADSC affected by TCS. MATERIALS AND METHODS: ADSCs from were analyzed for their stemness properties and shared many characteristics with those of a healthy subject. Screening of the genome of the TCS patient using array-Comparative Genomic Hybridization allowed us to identify some chromosomal imbalances that are probably associated with TCS. RESULTS: We found that some alterations, involving the TIMELESS gene, were usually associated with embryonic stem cells. CONCLUSIONS: With the aim to improve the final results, we need to consider combining knowledge of genetic alterations and expression profiles as a fundamental step before starting with surgical procedures.


Subject(s)
Mandibulofacial Dysostosis , Plastic Surgery Procedures , Female , Humans , Mandibulofacial Dysostosis/etiology , Mandibulofacial Dysostosis/genetics , Comparative Genomic Hybridization , Mutation , Stem Cells
2.
Eur Rev Med Pharmacol Sci ; 27(3 Suppl): 18-28, 2023 04.
Article in English | MEDLINE | ID: mdl-37129332

ABSTRACT

OBJECTIVE: Dupuytren contracture (DC) is a highly prevalent hand affection in which contracted fingers compromise hand function. It is a benign fibroproliferative condition affecting the hand palmar fascia with a deposition of excess matrix proteins in the extracellular space of the palmar aponeurosis. In particular type III over type I collagen V. Alginolyticus collagenase (CVA), is a new enzyme that is fully active on the collagen filaments and inactive on other components of the dermal extracellular matrix. The aim of this study is to evaluate the safety and effectiveness of an intra-lesional injection of CVA on an animal model of subcutaneous fibrosis mimicking the pathological anatomy of the cord of Dupuytren's disease. MATERIALS AND METHODS: We performed an in vivo study on 27 rats that were randomized into four groups, and we evaluated macroscopic and microscopic analysis examining the inflamed cell population and the extracellular matrix. RESULTS: In all cases, no skin necrosis, skin tears or wound dehiscence were recorded, demonstrating the safety of the CVA in contrast to group D which had full-thickness skin necrosis, and this is confirmed by the microscopic analysis of the samples treated with CVA, where no hematomas are found around the fibrotic area with the absence of leukocyte infiltrates and macrophages. CONCLUSIONS: CVA is confirmed to be selective for collagens I and III, reducing the risk of vascular lesions or skin ulcerations.


Subject(s)
Dupuytren Contracture , Animals , Rats , Dupuytren Contracture/metabolism , Vibrio alginolyticus , Hand , Collagenases , Necrosis
3.
Eur Rev Med Pharmacol Sci ; 26(3 Suppl): 1-10, 2022 12.
Article in English | MEDLINE | ID: mdl-36591885

ABSTRACT

Additive manufacturing (AM) has increasing applications in medicine in recent times. This technology has emerged in cardiovascular medicine as an intelligent system for the improvement of medical devices, the preparation of patient-specific models, and the prototyping of grafts. This review traces the research and development in the production of surgical guides and synthetic grafts for cardiac and vascular applications over the last few years. It also traces the recent widespread use of 3D-printed specific-patient models for cardiovascular surgical interventions. A current view of AM strategies, materials and solutions to improve cardiovascular patient outcomes is also provided.

4.
Eur Rev Med Pharmacol Sci ; 26(3 Suppl): 11-20, 2022 12.
Article in English | MEDLINE | ID: mdl-36591886

ABSTRACT

OBJECTIVE: A hernia of the abdominal wall is an opening of the muscles in the abdominal wall, which is frequently treated via the application of a surgical mesh. The purpose of this research is to study how human adipose-derived stem cells (hADSCs) interact with Phasix™ Mesh, a commercially available mesh for hernia repair. Studying how cells derived from the abdominal region behave with Phasix™ Mesh is crucial to improve the state of the art of current surgery and achieve effective tissue restoration. MATERIALS AND METHODS: hADSCs were seeded onto Phasix™ Mesh, a fully resorbable surgical mesh of poly (4-hydroxybutyric acid) (P4HB). Cell viability was assessed through MTT assay, and cell growth and adhesion were evaluated via multiple imaging techniques and gene imaging profiling. RESULTS: Results confirm that the nets support cells proliferation, extracellular matrix production and increasing of angiogenetic factor. CONCLUSIONS: Butyric acid-based nets are promising scaffolds for abdominal wall reconstruction.


Subject(s)
Abdominal Wall , Hernia, Ventral , Humans , Abdominal Wall/surgery , Tissue Engineering , Butyric Acid , Herniorrhaphy/methods , Prostheses and Implants , Surgical Mesh , Hernia, Ventral/surgery
5.
Eur Rev Med Pharmacol Sci ; 26(3 Suppl): 21-25, 2022 12.
Article in English | MEDLINE | ID: mdl-36591887

ABSTRACT

Many studies show that surgical hernia repair with the use of prosthetic meshes can result in pain, hernia recurrence, contraction and mesh rupture. Numerous experimental studies have been conducted to understand the effect of mesh stiffness, pore size and mesh patterns on mesh biocompatibility. The purpose of this mini review is to present an overview of the contracture, adhesion, tissue regrowth and histological response characteristics of permanent and absorbable mesh. Indeed, the mechanics of mesh-human tissue interaction is poorly understood in the literature. It has been shown that early integration of biological meshes is critical for sustained hernia repair. One of the emerging experimental approaches is to combine cell-based regenerative medicine with mesh materials. Studies in preclinical models show that the use of synthetic and biological meshes with autologous cell implantation improves the biocompatibility of biomaterials, promoting key tissue regeneration processes such as adhesion and vascularisation.


Subject(s)
Biological Products , Hernia, Ventral , Humans , Surgical Mesh , Prostheses and Implants , Wound Healing , Hernia, Ventral/surgery
6.
Eur Rev Med Pharmacol Sci ; 25(13): 4440, 2021 07.
Article in English | MEDLINE | ID: mdl-34286481

ABSTRACT

Correction to: European Review for Medical and Pharmacological Sciences 2021; 25 (8): 3350-3364-DOI: 10.26355/eurrev_202104_25747-PMID: 33928623, published online 30 April, 2021. After publication, the authors requested to correct the Acknowledgements of the above-mentioned article. There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/25747.

7.
Eur Rev Med Pharmacol Sci ; 25(8): 3350-3364, 2021 04.
Article in English | MEDLINE | ID: mdl-33928623

ABSTRACT

OBJECTIVE: The purpose of this article was to review our clinical experience with COVID-19 patients observed in the Cardiovascular Division of Pompidou Hospital (University of Paris, France) and the Department of Neurology of the Eastern Piedmont University (Novara, Italy), related to the impact on the cardiovascular, hematological, and neurologic systems and sense organs. PATIENTS AND METHODS: We sought to characterize cardiovascular, hematological, and neurosensory manifestations in patients with COVID-19 and variants. Special attention was given to initial signs and symptoms to facilitate early diagnosis and therapy. Indications of ECMO (extracorporeal membrane oxygenation) for cardiorespiratory support were evaluated. RESULTS: Preliminary neurosensorial symptoms, such as anosmia and dysgeusia, are useful for diagnosis, patient isolation, and treatment. Early angiohematological acro-ischemic syndrome includes hand and foot cyanosis, Raynaud digital ischemia phenomenon, skin bullae, and dry gangrene. This was associated with neoangiogenesis, vasculitis, and vessel thrombosis related to immune dysregulation, resulting from "cytokine storm syndrome". The most dangerous complication is disseminated intravascular coagulation, with mortality risks for both children and adults. CONCLUSIONS: COVID-19 is a prothrombotic disease with unique global lethality. A strong inflammatory response to viral infection severely affects cardiovascular and neurological systems, as well as respiratory, immune, and hematological systems. Rapid identification of acro-ischemic syndrome permits the treatment of disseminated intravascular coagulation complications. Early sensorial symptoms, such as gustatory and olfactory loss, are useful for COVID-19 diagnosis. New variants of SARS-CoV-2 are emerging, principally from United Kingdom, South Africa, and Brazil. These variants seem to spread more easily and quickly, which may lead to more cases of COVID.


Subject(s)
Anosmia/physiopathology , COVID-19/physiopathology , Cyanosis/physiopathology , Disseminated Intravascular Coagulation/physiopathology , Dysgeusia/physiopathology , Myocarditis/physiopathology , Raynaud Disease/physiopathology , Vasculitis/physiopathology , COVID-19/pathology , COVID-19/therapy , COVID-19/virology , Coronavirus 3C Proteases/ultrastructure , Cytokine Release Syndrome , Disseminated Intravascular Coagulation/pathology , Extracorporeal Membrane Oxygenation , Foot/blood supply , France , Gangrene/pathology , Gangrene/physiopathology , Hand/blood supply , Humans , Ischemia/pathology , Ischemia/physiopathology , Noninvasive Ventilation , Plasma Exchange , Raynaud Disease/pathology , SARS-CoV-2 , Spike Glycoprotein, Coronavirus/ultrastructure , Synchrotrons , Vasculitis/pathology
8.
Biotechnol Adv ; 34(5): 740-753, 2016.
Article in English | MEDLINE | ID: mdl-27086202

ABSTRACT

Bone tissue engineered 3-D constructs customized to patient-specific needs are emerging as attractive biomimetic scaffolds to enhance bone cell and tissue growth and differentiation. The article outlines the features of the most common additive manufacturing technologies (3D printing, stereolithography, fused deposition modeling, and selective laser sintering) used to fabricate bone tissue engineering scaffolds. It concentrates, in particular, on the current state of knowledge concerning powder-based 3D printing, including a description of the properties of powders and binder solutions, the critical phases of scaffold manufacturing, and its applications in bone tissue engineering. Clinical aspects and future applications are also discussed.


Subject(s)
Bone Substitutes , Bone and Bones , Printing, Three-Dimensional , Tissue Engineering , Tissue Scaffolds , Bone and Bones/cytology , Bone and Bones/physiology , Humans
9.
N Z Vet J ; 64(3): 188-92, 2016 May.
Article in English | MEDLINE | ID: mdl-26617346

ABSTRACT

CASE HISTORY: A 15-year-old female huacaya alpaca (Vicugna pacos) was referred because of a non-weight-bearing lameness (4/4) in the left pelvic limb caused by a grade three open metatarsal fracture. The referring veterinarian treated the fracture with conservative management using bandages, but it progressively evolved to a non-union. CLINICAL FINDINGS AND DIAGNOSIS: Clinical examination revealed external wounds on the medial and lateral surfaces of the metatarsus. Radiographs confirmed an open, nonarticular, displaced, diaphyseal fracture of the left metatarsus. TREATMENT AND OUTCOME: Cancellous bone was sourced from bovine proximal and distal femur epiphyses, followed by a thermal shock procedure to achieve decellularisation, to produce a xenograft. Open reduction and internal fixation of the fracture using locking plates was performed. Alignment of the fracture fragments was corrected and the xenograft was placed at the debrided fracture site to stimulate and harness osteogenesis in situ. Clinical and radiographic follow-up was performed up to 40 weeks postoperatively. Clinical evaluations revealed that the alpaca gradually increased weight bearing following bandage removal 10 days after surgery. Serial radiographs showed correct alignment of the left metatarsus, progressive bone modelling and, complete bone union at 12 weeks. Ten months postoperatively the alpaca showed no signs of lameness and resumed normal activity. CLINICAL RELEVANCE: For management of a metatarsal non-union, a combination of bovine xenograft application and angular stable internal fixation progressed toward an excellent long-term recovery.


Subject(s)
Bone Transplantation/veterinary , Camelids, New World , Fractures, Ununited/veterinary , Heterografts , Animals , Bone Transplantation/methods , Cattle , Female , Fractures, Ununited/therapy , Heterografts/ultrastructure , Hindlimb/pathology , Internal Fixators
10.
Allergy ; 71(3): 403-11, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26613380

ABSTRACT

BACKGROUND: Vernal keratoconjunctivitis (VKC) is a severe ocular allergy with pathogenic mechanism poorly understood and no efficacious treatment. The aims of the study were to determine quantities and distribution of Hsp chaperones in the conjunctiva of VKC patients and assess their levels in conjunctival epithelial and fibroblast cultures exposed to inflammatory stimuli. METHODS: Hsp10, Hsp27, Hsp40, Hsp60, Hsp70, Hsp90, Hsp105, and Hsp110 were determined in conjunctiva biopsies from nine patients and nine healthy age-matched normal subjects, using immunomorphology and qPCR. Conjunctival epithelial cells and fibroblasts were cultured and stimulated with IL-1ß, histamine, IL-4, TNF-α, or UV-B irradiation, and changes in Hsp levels were determined by Western blotting. RESULTS: Hsp27, Hsp40, Hsp70, and Hsp90 levels increased in the patients' conjunctiva, whereas Hsp10, Hsp60, Hsp100, and Hsp105 did not. Double immunofluorescence demonstrated colocalization of Hsp27, Hsp40, Hsp70, and Hsp90 with CD68 and tryptase. Testing of cultured conjunctival cells revealed an increase in the levels of Hsp27 in fibroblasts stimulated with IL-4; Hsp40 in epithelial cells stimulated with IL-4 and TNF-α and in fibroblasts stimulated with IL-4, TNF-α, and IL-1ß; Hsp70 in epithelial cells stimulated with histamine and IL-4; and Hsp90 in fibroblasts stimulated with IL-1ß, TNF-α, and IL-4. UV-B did not induce changes. CONCLUSIONS: VKC conjunctiva displays distinctive quantitative patterns of Hsps as compared with healthy controls. Cultured conjunctival cells respond to cytokines and inflammatory stimuli with changes in the Hsps quantitative patterns. The data suggest that interaction between the chaperoning and the immune systems drives disease progression.


Subject(s)
Conjunctivitis, Allergic/metabolism , Heat-Shock Proteins/metabolism , Molecular Chaperones/metabolism , Adolescent , Cells, Cultured , Child , Conjunctivitis, Allergic/diagnosis , Conjunctivitis, Allergic/genetics , Conjunctivitis, Allergic/immunology , Epithelial Cells/metabolism , Female , Fibroblasts/metabolism , Heat-Shock Proteins/genetics , Humans , Immunohistochemistry , Male , Molecular Chaperones/genetics
11.
Physiol Res ; 64(3): 427-32, 2015.
Article in English | MEDLINE | ID: mdl-26066976

ABSTRACT

One of the most abundant immunologic cell types in early decidua is the uterine natural killer (UNK) cell that despite the presence of cytoplasmic granules rich in perforin and granzymes does not degranulate in normal pregnancy. UNK cells are important producers of angiogenic factors that permit normal dilation of uterine arteries to provide increased blood flow for the growing feto-placental unit. Gram-negative bacteria lipopolysaccharide (LPS) administration can trigger an imbalance of pro-inflammatory and anti-inflammatory cytokines impairing the normal immune cells activity as well as uterine homeostasis. The present study aimed to evaluate by immunohistochemistry the reactivity of perforin and alpha-actin on UNK cell from LPS-treated pregnant mice. For the first time, we demonstrate that LPS injection in pregnant mice causes alpha-actin down regulation, concomitantly with perforin loss in UNK cells. This suggests that LPS alters UNK cell migration and activates cytotoxic granule release.


Subject(s)
Actins/metabolism , Killer Cells, Natural/metabolism , Lipopolysaccharides/pharmacology , Perforin/metabolism , Uterus/metabolism , Uterus/pathology , Animals , Down-Regulation/drug effects , Female , Killer Cells, Natural/drug effects , Mice , Pregnancy , Uterus/drug effects
12.
Physiol Res ; 61(5): 551-3, 2012.
Article in English | MEDLINE | ID: mdl-22881228

ABSTRACT

Lipopolysaccharide (LPS), produced by gram-negative bacteria, mediates vasodilatation, changing the action of contractile smooth muscle by increasing expression of nitric oxide synthase and prostaglandin. For the first time we demonstrate, by immunohistochemical methods, that administration of LPS to pregnant mice causes alpha-actin-mediated down-regulation of contractile filaments in uterine blood vessels, thereby potentially increasing vessels permeability, blood supply, and immune cells homing to this environment, culminating in the reestablishment of uterine homeostasis.


Subject(s)
Actins/blood , Lipopolysaccharides/pharmacology , Pregnancy/blood , Pregnancy/drug effects , Uterine Artery/cytology , Uterine Artery/metabolism , Animals , Down-Regulation , Female , Mice
13.
Clin Exp Allergy ; 41(1): 52-60, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20977504

ABSTRACT

BACKGROUND: Vernal keratoconjunctivitis (VKC) is a chronic ocular allergic inflammation characterized by corneal complications and the formation of giant papillae. Sma- and Mad-related proteins (Smad) modulate extracellular matrix gene expression during wound healing, inflammation and tissue remodelling. OBJECTIVE: To investigate the relationship between allergic inflammation and TGF-ß/Smad signalling pathway, expression in VKC patients and in primary cultured conjunctival fibroblasts exposed to mediators found previously over-expressed in VKC. METHODS: Smad-2, -3, -7, phospho-(p)Smads, TGF-ß1 and -ß2 were evaluated in the conjunctiva of normal subjects (CT) and VKC patients by immunohistochemistry. The expression of Smads, pro-collagen I (PIP), TGF-ß1, -ß2, mitogen-activated protein kinase (p38/MAPK), c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK1/2) were also determined in conjunctival fibroblast cultures exposed to histamine, IL-4, -13, TGF-ß1, IFN-γ and TNF-α using immunostaining or RT-PCR. RESULTS: Immunostaining for Smad-2, -3, pSmad-2, -3, TGF-ß1, -ß2 and PIP was significantly increased in VKC stroma compared with CT. In conjunctival fibroblast cultures, Smad-3 and PIP were stimulated by histamine, IL-4, -13 and TGF-ß1 exposure, while PIP was reduced by IFN-γ, and TNF-α mRNA expression of Smad-3 was increased by histamine, while Smad-7 was reduced by IL-4. In addition, histamine, IL-4 and TNF-α increased JNK and ERK1/2 expression. CONCLUSION AND CLINICAL RELEVANCE: The TGF-ß/Smad signalling pathway is over-expressed in VKC tissues and modulated in conjunctival fibroblasts by histamine, IL-4, TGF-ß1 and TNF-α. These mechanisms may be involved in fibrillar collagen production, giant papillae formation and tissue remodelling typical of VKC and might provide new therapeutic targets for its treatment.


Subject(s)
Conjunctiva/immunology , Conjunctivitis, Allergic/immunology , Models, Immunological , Signal Transduction/immunology , Smad Proteins/immunology , Transforming Growth Factor beta/immunology , Adolescent , Child , Conjunctivitis, Allergic/diagnosis , Conjunctivitis, Allergic/genetics , Female , Humans , Male , RNA, Messenger/genetics , RNA, Messenger/immunology , Reverse Transcriptase Polymerase Chain Reaction , Smad Proteins/genetics , Transforming Growth Factor beta/genetics
14.
Pharmacogenomics J ; 10(5): 408-17, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20029385

ABSTRACT

Atypical antipsychotics (APDs) are currently used in clinical practice for a variety of mental disorders such as schizophrenia, bipolar disorder and severe behavioral disturbances. A well-known disadvantage of using these compounds is a propensity for weight gain, resulting frequently in obesity. The mechanisms underlying pharmacologically induced weight gain are still controversial. The objective of this study was to evaluate in vitro the effects of different APDs on adipogenic events in cultured human pre-adipocytes and in rat muscle-derived stem cells (MDSCs), aiming to identify a common intracellular event contributable to these drugs. Culture behavior was evaluated in terms of cell proliferation, lipid accumulation, gene expression and morphological features. Results indicate that APDs influence adipogenic events through changes in the differentiation and proliferation of pre-adipocytes and MDSCs that are brought on by protein kinase C-ß (PKC-ß) activation. These data identify a signaling route that could be a potential target of pharmacological approaches for preventing the weight gain associated with APD treatment.


Subject(s)
Adipocytes/drug effects , Adipogenesis/drug effects , Antipsychotic Agents/adverse effects , Protein Kinase C/metabolism , Stem Cells/drug effects , Weight Gain/drug effects , Adipocytes/cytology , Adipocytes/enzymology , Adipogenesis/genetics , Animals , Animals, Newborn , Cell Culture Techniques , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Enzyme Activation , Gene Expression/drug effects , Gene Silencing/drug effects , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/genetics , Protein Kinase C beta , RNA, Small Interfering/genetics , RNA, Small Interfering/pharmacology , Rats , Stem Cells/cytology , Stem Cells/enzymology , Weight Gain/genetics
15.
J Mater Sci Mater Med ; 20(1): 235-47, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18758917

ABSTRACT

The present study describes the production of hyaluronan based porous microparticles by a semi-continuous gas anti-solvent (GAS) precipitation process to be used as a growth factor delivery system for in vivo treatment of ulcers. Operative process conditions, such as pressure, nozzle diameter and HYAFF11 solution concentrations, were adjusted to optimize particle production in terms of morphology and size. Scanning electron microscopy (SEM) and light scattering demonstrated that porous nano-structured particles with a size of 300 and 900 nm had a high specific surface suitable for absorption of growth factors from the aqueous environment within the polymeric matrix. Water acted as a plasticizer, enhancing growth factor absorption. Water contents within the HYAFF11 matrix were analyzed by differential scanning calorimetry (DSC). The absorption process was developed using fluorescence dyes and growth factors. Immunohistochemical analysis confirmed the high efficiency of absorption of growth factor and a mathematical model was generated to quantify and qualify the in vitro kinetics of growth factor release within the polymeric matrix. In vivo experiments were performed with the aim to optimize timed and focal release of PDGF to promote optimal tissue repair and regeneration of full-thickness wounds.


Subject(s)
Biocompatible Materials/chemistry , Growth Substances/administration & dosage , Hyaluronic Acid/chemistry , Nanoparticles/chemistry , Nanoparticles/therapeutic use , Skin Ulcer/therapy , Absorption , Animals , Male , Materials Testing , Microscopy, Electron, Scanning , Nanoparticles/ultrastructure , Nanotechnology/instrumentation , Platelet-Derived Growth Factor/administration & dosage , Rats , Rats, Wistar , Skin Ulcer/drug therapy , Skin Ulcer/pathology , Tissue Scaffolds , Transforming Growth Factor beta/administration & dosage , Water/chemistry , Wound Healing/drug effects
16.
Eur J Histochem ; 51 Suppl 1: 1-8, 2007.
Article in English | MEDLINE | ID: mdl-17703587

ABSTRACT

Hyaluronan-based scaffold were used for in vitro commitment of human and rat bone marrow mesenchymal stem cells (MSC). Cells were cultured either in monolayer and in 3D conditions up to 35 days. In order to monitor the differentiating processes molecular biology and morphological studies were performed at different time points. All the reported data supported the evidence that both human and rat MSC grown onto hyaluronan-derived three-dimensional scaffold were able to acquire a unique phenotype of chondrocytes and osteocytes depending on the presence of specific differentiation inducing factors added into the culture medium without significative differences in term of time expression of extracellular matrix proteins.


Subject(s)
Adult Stem Cells/cytology , Chondrocytes/cytology , Mesenchymal Stem Cells/cytology , Adult Stem Cells/metabolism , Adult Stem Cells/ultrastructure , Animals , Bone Marrow Cells , Cell Differentiation , Cell Proliferation , Cells, Cultured , Chondrocytes/metabolism , Chondrogenesis/physiology , Collagen Type I/genetics , Collagen Type I/metabolism , Collagen Type II/genetics , Collagen Type II/metabolism , Flow Cytometry , Humans , Mesenchymal Stem Cells/metabolism , Mesenchymal Stem Cells/ultrastructure , Osteocalcin/genetics , Osteocalcin/metabolism , Osteogenesis , Osteonectin/genetics , Osteonectin/metabolism , Osteopontin/genetics , Osteopontin/metabolism , Rats , Rats, Inbred F344 , Reverse Transcriptase Polymerase Chain Reaction
17.
J Biomed Mater Res A ; 82(1): 213-21, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17266017

ABSTRACT

In this study we coated a new biocompatible, nanostructured titanium alloy, Ti13Nb13Zr, with a thin layer of hydroxyapatite nanocrystals and we investigated the response of human bone-marrow-derived mesenchymal cells. The coating was realized using a slightly supersaturated CaP solution, which provokes a fast deposition of nanocrystalline hydroxyapatite. A thin layer of deposition is appreciable on the etched Ti13Nb13Zr substrates after just 1.5 h soaking in the CaP solution, and it reaches a thickness of 1-2 mum after 3 h soaking. The coating seems thinner than that deposited on Ti6Al4V, which was examined for comparison, likely because of the different roughness profiles of the two etched alloys, and it is constituted of elongated HA nanocrystals, with a mean length of about 100 nm. Mesenchymal stem cells were seeded onto coated and uncoated Ti alloys and cultured for up to 35 days. Cell morphology, proliferation and differentiation were evaluated. The cells display good adhesion and proliferation on the uncoated substrates, whereas the presence of hydroxyapatite coating slightly reduces cell proliferation and induces differentiation of MSCs towards a phenotypic osteoblastic lineage, in agreement with the increase of the expression of osteopontin, osteonectin and collagen type I, evaluated by means of rt-PCR. Type I collagen expression is higher in Ti13Nb13Zr MSC culture compared to Ti6Al4V, standing for a more efficient extracellular matrix deposition.


Subject(s)
Coated Materials, Biocompatible/chemistry , Durapatite/chemistry , Mesenchymal Stem Cells/cytology , Nanoparticles/chemistry , Titanium/chemistry , Alloys/chemistry , Base Sequence , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Cell Adhesion , Cell Culture Techniques/methods , Cell Differentiation , Cell Proliferation , Collagen Type I/genetics , DNA Primers/genetics , Gene Expression , Humans , Materials Testing , Mesenchymal Stem Cells/metabolism , Microscopy, Electron, Scanning , Osteoblasts/cytology , Osteoblasts/metabolism , Osteonectin/genetics , Osteopontin/genetics
18.
Eur J Vasc Endovasc Surg ; 32(4): 411-7, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16678455

ABSTRACT

OBJECTIVE: To evaluate a new Hyaluronan-based graft. MATERIAL AND METHODS: Hyaluronan-based grafts (HYAFF 11trade mark tube, diameter 2 mm, length 1.5 cm) were implanted in an end-to-end fashion in the abdominal aorta of 15 rats. Histology, immunohistochemistry and electron microscopy were used to evaluate the results at 7, 21, and 90 days. RESULTS: At day 7, new tissue was observed in the graft coming from both the proximal and distal ends of the aorta. The luminal surface of the regenerating tissue was covered by endothelial cells (CD34(+), VEGFR-2(+), vWF(+)). At day 21, regenerating tissue joined at the centre of the tube. The neo-vessel was formed by smooth muscle cells (Myosin Light Chain Kinase) as well as elastic, and collagen fibres. At day 90 a stable artery segment was formed and the biomaterial was almost completely degraded. Infiltration of neutrophils and lymphocytes was not observed. All animals survived the observation period and there were no signs of stenoses or aneurysms. CONCLUSION: The hyaluronan-based graft allowed complete regeneration of a newly formed vascular tube in which all the cellular and extracellular components are present and organized in a well defined architecture similar to native artery.


Subject(s)
Absorbable Implants , Blood Vessel Prosthesis , Hyaluronic Acid , Tissue Engineering , Animals , Aorta, Abdominal/surgery , Arteries/surgery , Biocompatible Materials , Blood Vessel Prosthesis Implantation , Cells, Cultured , Endothelium, Vascular/cytology , Male , Rats , Rats, Sprague-Dawley
19.
Biomaterials ; 26(34): 7038-45, 2005 Dec.
Article in English | MEDLINE | ID: mdl-15993941

ABSTRACT

Tissue engineering is a promising approach to developing hepatic tissue suitable for the functional replacement of a failing liver. The aim of the present study was to investigate whether an extracellular cell matrix obtained from fibroblasts-cultured within scaffolds of hyaluronic acid (HYAFF) could influence the proliferation rate and survival of rat hepatocytes both during long-term culture and after in vivo transplantation. Cultures were evaluated by histological and morphological analysis, a proliferation assay and metabolic activity (albumin secretion). Hepatocytes cultured in extracellular matrix-enriched scaffolds exhibited a round cellular morphology and re-established cell-cell contacts, growing into aggregates of several cells along and/or among fibers in the fabric. Hepatocytes were able to secrete albumin up to 14 days in culture. In vivo results demonstrated the biocompatibility of HYAFF-11 implanted in nude mice, in which hepatocytes maintained small well-organised aggregates until the 35th day. In conclusion, the presence of a fibroblast-secreted extracellular matrix improved the biological properties of the hyaluronan scaffold, favoring the survival and morphological integrity of hepatocytes in vitro and in vivo.


Subject(s)
Extracellular Matrix/metabolism , Fibroblasts/metabolism , Hepatocytes/cytology , Hepatocytes/transplantation , Hyaluronic Acid/chemistry , Liver, Artificial , Tissue Engineering/methods , Animals , Biocompatible Materials/chemistry , Cell Culture Techniques/methods , Cell Proliferation , Cell Survival/physiology , Cells, Cultured , Hepatocytes/physiology , Humans , Materials Testing , Mice , Mice, SCID , Rats , Rats, Wistar
20.
Biomaterials ; 24(7): 1205-11, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12527261

ABSTRACT

Experiences coming from many cell-culture studies has brought about the concept that tissue and organ reconstruction should be performed in a three-dimensional environment as it normally occurs in vivo. As far as endothelial cell culture is concerned, it has been shown that angiogenesis can be successfully achieved only when cells are cultured in the presence of collagen-based matrices or basal membrane substrates. The aim of the present investigation is to demonstrate that human umbilical vein endothelial cells (HUVEC) can be grown and differentiated on an artificial dermis obtained by fibroblasts cultured on hyaluronic acid-based scaffolds. For this purpose, we have cultured HUVEC, retrieved by collagenase digestion of perfused human umbilical vein either alone and with fibroblast at 1/1 ratio into HYAFF-11 non-woven mesh. Cultures were maintained for up to 3 weeks. Samples were taken at different time points within this period for the MTT proliferation test and for immunohistochemical analysis. Our results demonstrate that hyaluronan-based biomaterials (HYAFF-11 NW mesh) represent a suitable substrate for HUVEC adhesion, proliferation and reorganization in microcapillary network.


Subject(s)
Biocompatible Materials , Endothelium, Vascular/physiology , Fibronectins/physiology , Skin, Artificial , Umbilical Veins/cytology , Cell Adhesion/drug effects , Cell Culture Techniques , Collagen/analogs & derivatives , Endothelium, Vascular/cytology , Fibronectins/biosynthesis , Fibronectins/pharmacology , Humans , Keratinocytes/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...